Matches in UGent Biblio for { <https://biblio.ugent.be/publication/5638696#aggregation> ?p ?o. }
Showing items 1 to 47 of
47
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B1002192.
- aggregation creator B1002193.
- aggregation creator B1002194.
- aggregation creator B1002195.
- aggregation creator B1002196.
- aggregation creator B1002197.
- aggregation creator B1002198.
- aggregation creator B1002199.
- aggregation creator B1002200.
- aggregation creator B1002201.
- aggregation creator B1002202.
- aggregation creator B1002203.
- aggregation creator person.
- aggregation creator person.
- aggregation date "2012".
- aggregation format "application/pdf".
- aggregation hasFormat 5638696.bibtex.
- aggregation hasFormat 5638696.csv.
- aggregation hasFormat 5638696.dc.
- aggregation hasFormat 5638696.didl.
- aggregation hasFormat 5638696.doc.
- aggregation hasFormat 5638696.json.
- aggregation hasFormat 5638696.mets.
- aggregation hasFormat 5638696.mods.
- aggregation hasFormat 5638696.rdf.
- aggregation hasFormat 5638696.ris.
- aggregation hasFormat 5638696.txt.
- aggregation hasFormat 5638696.xls.
- aggregation hasFormat 5638696.yaml.
- aggregation isPartOf urn:issn:0003-4967.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database".
- aggregation abstract "Objectives: Systemic sclerosis (SSc) is a rare disease requiring multicentre collaboration to reveal comprehensive details of disease-related causes for morbidity and mortality. Methods: The European League Against Rheumatism (EULAR) Scleroderma Trials and Research (EUSTAR) group initiated a database to prospectively gather key data of patients with SSc using a minimal essential dataset that was reorganised in 2008 introducing new items. Baseline visit data of patients who were registered between 2004 and 2011 were analysed using descriptive statistics. Results: In June 2011, 7655 patients (2838 with diffuse cutaneous (dc) and 4481 with limited cutaneous (lc) SSc who fulfilled the American College of Rheumatology diagnostic criteria had been registered in 174 centres, mainly European. The most prominent hallmarks of disease were Raynaud's phenomenon (96.3%), antinuclear antibodies (93.4%) and a typical capillaroscopic pattern (90.9%). Scleroderma was more common on fingers and hands than on any other part of the skin. Proton pump inhibitors (65.2%), calcium channel blockers (52.7%), and corticosteroids (45.3%) were most often prescribed. Among the immunosuppressant agents, cyclophosphamide was used more often in dcSSc than in lcSSc. Conclusions: The EUSTAR database provides an abundance of information on the true clinical face of SSc that will be helpful in improving the classification of SSc and its subsets and for developing more specific therapeutic recommendations.".
- aggregation authorList BK1408347.
- aggregation endPage "1360".
- aggregation issue "8".
- aggregation startPage "1355".
- aggregation volume "71".
- aggregation aggregates 5638931.
- aggregation aggregates 5664467.
- aggregation aggregates 5664468.
- aggregation isDescribedBy 5638696.
- aggregation similarTo annrheumdis-2011-200742.
- aggregation similarTo LU-5638696.